
Business
West Chester's Verrica Pharmaceuticals reports Q2 earnings Thursday
West Chester-based Verrica Pharmaceuticals will report second-quarter 2026 financial results Thursday, Aug. 6, in its first earnings call since signing an $8.2 million Israel licensing deal and dosing the first patient in a new common-warts trial.







